Merck drug extends survival in endometrial cancer trial, wins U.S. priority review
The drug delivers a cancer-killing payload to cells that carry a protein common in endometrial tumours
Attributed summary
The drug delivers a cancer-killing payload to cells that carry a protein common in endometrial tumours
Read the original report — The Hindu Health
Storywire publishes attributed summaries for discoverability. Full reporting remains with the original publisher — we do not republish restricted full text.
